Poly Medicure Stock Screener | Share Price & Fundamental Analysis
POLYMED
Medical Equipment
Share Price NSE
₹1256.10
▼
-2.60 (-0.21%)
Share Price BSE
₹1266.40
▲
6.70 (0.53%)
Track Poly Medicure share price live with TickJournal's free stock screener.
Analyze Poly Medicure share price history trends and compare 52-week high low
levels.
Calculate POLYMED stock fair value using fundamental analysis and view live share price charts.
Determine Poly Medicure share intrinsic value and compare it with current POLYMED share price.
Record your Poly Medicure trades in TickJournal's free trading journal and track your portfolio performance.
Poly Medicure Market Cap
₹12,731.77 Cr.
POLYMED P/E Ratio (TTM)
36.74
EPS (TTM)
₹34.13
Dividend Yield
0.28%
Debt to Equity
0.08
POLYMED 52 Week High
₹2835.20
Poly Medicure 52 Week Low
₹1255.80
Operating Margin
27.00%
Profit Margin
19.70%
POLYMED Revenue (TTM)
₹467.00
EBITDA
₹146.00
Net Income
₹92.00
Total Assets
₹3,193.00
Total Equity
₹2,766.00
Poly Medicure Share Price History - Stock Screener Chart
Screen POLYMED historical share price movements with interactive charts. Analyze price trends and patterns.
Poly Medicure Company Profile - Fundamental Screener
Screen Poly Medicure company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for POLYMED shares.
Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and...more
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
Chairperson/CEO
Devendra Raj Mehta
ISIN
INE205C01021
Website
https://www.polymedicure.com
Poly Medicure Balance Sheet Screener
Screen POLYMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,193 | 1,859 | 1,577 | 1,377 | 1,224 | 767 | 654 | 565 | 457 | 387 |
| Current Assets | 1,917 | 842 | 807 | 783 | 704 | 318 | 302 | 255 | 205 | 171 |
| Fixed Assets | 1,084 | 867 | 635 | 488 | 426 | 363 | 306 | 265 | 207 | 182 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 57 | 37 | 42 | 63 | 87 | 135 | 119 | 104 | 72 | 50 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,766 | 1,470 | 1,242 | 1,088 | 966 | 435 | 381 | 338 | 272 | 229 |
| Share Capital | 51 | 48 | 48 | 48 | 48 | 44 | 44 | 44 | 44 | 22 |
| Reserves & Surplus | 2,715 | 1,422 | 1,194 | 1,040 | 918 | 391 | 337 | 294 | 227 | 207 |
Poly Medicure Income Statement Screener - Profit & Revenue Analysis
Screen Poly Medicure income statement and profit fundamentals.
Analyze POLYMED quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Poly Medicure share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 467 | 447 | 479 | 522 | 393 | 402 | 447 | 448 | 316 | 335 | 352 | 357 | 266 | 254 | 284 |
| Expenses | 321 | 298 | 329 | 389 | 282 | 281 | 305 | 310 | 224 | 234 | 253 | 249 | 202 | 202 | 210 |
| EBITDA | 146 | 149 | 150 | 132 | 112 | 121 | 142 | 138 | 92 | 101 | 99 | 108 | 64 | 51 | 74 |
| Operating Profit % | 27.00% | 26.00% | 26.00% | 21.00% | 26.00% | 27.00% | 27.00% | 27.00% | 27.00% | 27.00% | 25.00% | 27.00% | 22.00% | 19.00% | 24.00% |
| Depreciation | 21 | 23 | 25 | 29 | 16 | 20 | 21 | 21 | 15 | 16 | 16 | 16 | 14 | 14 | 14 |
| Interest | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 4 | 2 | 1 | 0 |
| Profit Before Tax | 123 | 123 | 122 | 98 | 93 | 99 | 118 | 113 | 75 | 83 | 81 | 88 | 49 | 36 | 59 |
| Tax | 31 | 30 | 30 | 27 | 24 | 24 | 31 | 28 | 16 | 20 | 19 | 23 | 13 | 9 | 16 |
| Net Profit | 92 | 93 | 92 | 71 | 68 | 74 | 87 | 85 | 59 | 63 | 62 | 65 | 36 | 27 | 44 |
| EPS | 8.92 | 9.19 | 9.06 | 7.00 | 7.12 | 7.71 | 9.01 | 8.48 | 6.13 | 6.54 | 6.48 | 6.78 | 3.77 | 2.81 | 4.53 |
Poly Medicure Cash Flow Screener - Liquidity Fundamentals
Screen POLYMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 240 | 266 | 191 | 124 | 119 | 131 | 107 | 75 | 56 | 63 |
| Investing Activities | -1,194 | -241 | -179 | -85 | -436 | -110 | -101 | -88 | -56 | -31 |
| Financing Activities | 951 | -20 | -13 | -35 | 317 | -21 | -5 | 16 | 0 | -31 |
| Net Cash Flow | -3 | 5 | -1 | 3 | 0 | 1 | 1 | 3 | 0 | 1 |
Poly Medicure Shareholding Pattern Screener
See Poly Medicure shareholding pattern with promoter, FII, and DII holdings.
Check Poly Medicure promoter holding and ownership changes for POLYMED on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Aug | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.44% | 62.44% | 62.42% | 62.42% | 53.15% | 66.03% | 62.56% | 62.56% |
| FII Holding | 11.46% | 11.41% | 9.77% | 9.40% | 12.38% | 9.91% | 11.10% | 11.87% |
| DII Holding | 11.96% | 11.72% | 13.54% | 13.84% | 7.22% | 9.35% | 12.48% | 12.33% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.08% | 11.37% | 11.25% | 11.30% | 11.34% | 11.37% | 10.70% | 10.14% |
| Other Holding | 3.07% | 3.07% | 3.02% | 3.04% | 15.92% | 3.36% | 3.16% | 3.10% |
| Shareholder Count | 65,583 | 71,142 | 64,400 | 67,750 | 36,712 | 36,852 | 40,516 | 38,352 |
Poly Medicure Share Dividend Screener - Share Yield Analysis
Check Poly Medicure dividend history with payout and yield data.
View Poly Medicure dividend details including ex-dates and amounts for POLYMED stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹3.50 | 0.28% |
| 2024-March | ₹3.00 | 0.13% |
| 2023-March | ₹3.00 | 0.19% |
| 2022-March | ₹2.50 | 0.27% |
| 2021-March | ₹2.50 | 0.26% |
| 2020-March | ₹2.00 | 0.24% |
| 2019-March | ₹2.00 | 0.86% |
| 2018-March | ₹2.00 | 0.91% |
| 2017-March | ₹2.50 | 1.00% |
Poly Medicure Stock Index Membership
See which indices include Poly Medicure stock.
Check POLYMED index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Poly Medicure Market Events Screener - Corporate Actions
Get Poly Medicure corporate actions including splits, bonuses, and buybacks.
Check Poly Medicure stock events that may affect POLYMED share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.50 /share | -22.96% | ||
| Dividend | ₹ 2.50 /share | -15.86% | ||
| Dividend | ₹ 2.50 /share | 29.60% | ||
| Dividend | ₹ 3.00 /share | 44.20% | ||
| Dividend | ₹ 3.00 /share | 49.07% | ||
| Annual General Meeting | NA | -7.40% | ||
| Annual General Meeting | NA | -4.15% | ||
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 0.22% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -4.09% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -5.90% |
| 2025-05-06 | 2025-05-06 | Quarterly Result Announcement | NA | 0.10% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -0.55% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 2.55% |
| 2017-03-24 | 2017-03-28 | Bonus | 1:1 | - |
Poly Medicure Competitors Screener - Peer Comparison
Screen POLYMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 12,732 | 36.74 | 1,759 | 22.62% | 339 | 32.49 |
| Laxmi Dental | 1,058 | 45.52 | 242 | 24.12% | 25 | 42.66 |
| Tarsons Products | 1,015 | 50.46 | 408 | 32.64% | 30 | 39.54 |
| Osel Devices | 904 | 44.66 | 187 | 40.62% | 20 | 54.31 |
| Vasa Denticity | 779 | 59.53 | 173 | % | 15 | 30.31 |
| Fabtech Technologies | 667 | 21.83 | 336 | 45.66% | 47 | 33.43 |
| Prevest Denpro | 543 | 27.38 | 67 | 13.15% | 18 | 47.40 |
| Hemant Surgical Industries | 383 | 47.49 | 112 | % | 8 | 53.48 |
| Aprameya Engineering | 376 | 24.56 | 136 | 107.77% | 16 | 29.54 |
| Nureca | 295 | 26.72 | 122 | 19.24% | 1 | 54.15 |
Poly Medicure Company Announcements - News Screener
Screen POLYMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2026-02-13 | Statement Of Deviation And Variation For The Quarter Ended 31St December 2025 | View |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-05 | Grant Of 2000 Stock Options Under ESOS 2020 Of The Company. | View |
| 2026-02-05 | Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December 2025. | View |
| 2026-02-05 | Board Meeting Outcome for Otcome Of Board Meeting Held On Today I.E. 05Th February 2026 | View |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-29 | Board Meeting Intimation for Intimation For The Board Meeting To Be Held On 05Th February 2026 For Consider And Approve The Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended On 31St December 2025. | View |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-07 | Clarification On Increase In Volume | View |
| 2026-01-07 | Clarification sought from Poly Medicure Ltd | - |
| 2025-12-29 | Closure of Trading Window | View |
| 2025-12-18 | Investors/Analysts Virtual Call | View |
| 2025-11-22 | Intimation Of Investors/Analyst Virtual Calls | View |
| 2025-11-20 | Intimation Of Investors/Analyst Virtual Call On 24Th November 2025 | View |
| 2025-11-19 | Intimation Of Investotrs/Analyst Virtual Call On 24Th November 2025 | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |